Armenia vs China: Treatment success rate for patients treated for MDR-TB
Armenia
68.0%
in 2022
China
68.0%
in 2022
Armenia rank
104th
China rank
104th
Treatment success rate for patients treated for MDR-TB over time
- Armenia
- China
How they compare
Armenia currently reports 68.0% against 68.0% in China, a difference of 0.0%.
The two have swapped places 7 times across 15 shared years of data; in 2008 it was Armenia ahead.
Armenia ranks 104th and China ranks 104th of 163 countries.
Across the 3 decades both report, Armenia averaged higher in 2 and China in 1.
Head to head by decade
| Decade | Armenia | China | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 53.0% | 46.0% | 7.0% | Armenia |
| 2010s | 48.2% | 48.4% | 0.2% | China |
| 2020s | 67.3% | 61.7% | 5.7% | Armenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Armenia or China?
- Armenia, at 68.0% against 68.0% in China as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Armenia and China?
- 0.0%, with Armenia ahead.
- How many years of comparable data are there for Armenia and China?
- 15 years are reported by both, from 2008 to 2022.
- How do Armenia and China rank globally for treatment success rate for patients treated for mdr-tb?
- Armenia ranks 104th and China ranks 104th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.